Life Sciences & Health Consortium
Obtaining competitive intelligence is a vital part of any business, and especially for life science companies. Having access to the latest information on patents, developmental status of a comparative product, design and outcome of clinical trials and licensing deals done is a valuable asset, but often comes at a high price.
To provide access to this kind of information at an affordable price and allow companies to use this to bring their innovations faster to market, Life Sciences & Health has discussed the initiation of a consortium with Thomson Reuters for access to their pharmaceutical database, Thomson Pharma.
Under this consortium agreement Dutch small-to-medium sized companies and institutes can get access to their database at a substantially reduced rate.
Exclusively through the consortium agreement, you can request for a free trial to Thomson Pharma to assess the usefulness of this resource.
For more details on joining the consortium or requesting a trial period,
please fill out the form on the next page.